Saskia De Smet

Viable CD34+ stem cell content of a cord blood graft: which measurement performed before transplantation is most representative?

B. Vandekerckhove, Katrien Vanheusden, I. Van haute, 2004, Transfusion.

Treatment of a patient with severe cytomegalovirus (CMV) infection after haploidentical stem cell transplantation with donor derived CMV specific T cells

F. Baron, B. Vandekerckhove, G. Leclercq, 2020, Acta clinica Belgica.

Small-scale manufacturing of neoantigen-encoding messenger RNA for early-phase clinical trials.

B. Menten, F. Impens, B. Vandekerckhove, 2021, Cytotherapy.